Literature DB >> 29310784

Quantification of hyaluronan (HA) using a simplified fluorophore-assisted carbohydrate electrophoresis (FACE) procedure.

Ronald J Midura1, Valbona Cali2, Mark E Lauer2, Anthony Calabro2, Vincent C Hascall2.   

Abstract

Hyaluronan (HA) exhibits numerous important roles in physiology and pathologies, and these facts necessitate an ability to accurately and reproducibly measure its quantities in tissues and cell cultures. Our group previously reported a rigorous and analytical procedure to quantify HA (and chondroitin sulfate, CS) using a reductive amination chemistry and separation of the fluorophore-conjugated, unsaturated disaccharides unique to HA and CS on high concentration acrylamide gels. This procedure is known as fluorophore-assisted carbohydrate electrophoresis (FACE) and has been adapted for the detection and quantification of all glycosaminoglycan types. While this previous FACE procedure is relatively straightforward to implement by carbohydrate research investigators, many nonglycoscience laboratories now studying HA biology might have difficulties establishing this prior FACE procedure as a routine assay for HA. To address this need, we have greatly simplified our prior FACE procedure for accurate and reproducible assessment of HA in tissues and cell cultures. This chapter describes in detail this simplified FACE procedure and, because it uses an enzyme that degrades both HA and CS, investigators will also gain additional insight into the quantities of CS in the same samples dedicated for HA analysis.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-Aminoacridone; Chondroitin sulfate; Digital gel imaging; Fluorophore-assisted carbohydrate electrophoresis; Glycosaminoglycan; Hyaluronan

Mesh:

Substances:

Year:  2017        PMID: 29310784     DOI: 10.1016/bs.mcb.2017.08.017

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  4 in total

1.  Cardiac mesenchymal cells from failing and nonfailing hearts limit ventricular dilation when administered late after infarction.

Authors:  Timothy N Audam; Yibing Nong; Alex Tomlin; Andrea Jurkovic; Hong Li; Xiaoping Zhu; Bethany W Long; Yi Wei Zheng; Tyler Weirick; Kenneth R Brittian; Daniel W Riggs; Anna Gumpert; Shizuka Uchida; Yiru Guo; Marcin Wysoczynski; Steven P Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-22       Impact factor: 4.733

2.  The versican-hyaluronan complex provides an essential extracellular matrix niche for Flk1+ hematoendothelial progenitors.

Authors:  Sumeda Nandadasa; Anna O'Donnell; Ayako Murao; Yu Yamaguchi; Ronald J Midura; Lorin Olson; Suneel S Apte
Journal:  Matrix Biol       Date:  2021-01-14       Impact factor: 11.583

3.  Cardiac fibroblast activation and hyaluronan synthesis in response to hyperglycemia and diet-induced insulin resistance.

Authors:  Daniel J Gorski; Anne Petz; Christina Reichert; Sören Twarock; Maria Grandoch; Jens W Fischer
Journal:  Sci Rep       Date:  2019-02-12       Impact factor: 4.379

4.  Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103+ dendritic cells and in combination with PD-L1 blockade boosts anti-tumour immunity.

Authors:  Yeonsun Hong; Yoon Kyoung Kim; Gi Beom Kim; Gi-Hoon Nam; Seong A Kim; Yoon Park; Yoosoo Yang; In-San Kim
Journal:  J Extracell Vesicles       Date:  2019-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.